ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Tarsus Pharmaceuticals
The Vice President, Clinical Development provides strategic and scientific leadership for all clinical programs, overseeing trial design, execution, and data analysis from first‑in‑human through proof‑of‑concept and approval. The role focuses on creating adaptable early development strategies, building a high‑performing clinical organization, and partnering cross‑functionally to drive efficient, rigorous clinical work.
Tarsus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing novel therapies for diseases with high unmet need, with a primary focus on eye care. The company markets XDEMVY® (lotilaner ophthalmic solution) 0.25%, the first and only FDA-approved treatment for Demodex blepharitis, and has a pipeline targeting conditions such as ocular rosacea and Lyme disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tarsus Pharmaceuticals.
Senior Vice President Clinical Development
Qpex Biopharma
Vice President, Head of Clinical Development – Allergy & Urticaria
ARS Pharmaceuticals
Vice President, Medicine Development Leader
GSK plc
Sr. Principal Scientist, Clinical Operations Immunology Lead
MSD
Vice President, Clinical Development Program Leader (MD)
Madrigal Pharmaceuticals
Vice President, Medical Affairs, Clinical Operations & Regulatory Affairs
Dendreon Corporation